Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Pathology

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jcp.53.2.125PMID 10767828PMCID PMC1763294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance.

  1998cited by this paper
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Oestrogen receptors and breast cancer

  1997cited by this paper
• Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients

  1997cited by this paper
• A Phoenix Arisen-Estrogen Receptor Immunohistochemistry

  1997cited by this paper
• HIV associated tuberculosis

  1997cited by this paper
• Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment. The South Sweden Breast Cancer Group.

  1996cited by this paper
• Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.

  1996cited by this paper
• Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol‐based ligand‐binding assays

  1996cited by this paper
• pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

  1996cited by this paper
• Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing.

  1994cited by this paper
• Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.

  1993cited by this paper
• Production of monoclonal antibodies to human estrogen‐receptor protein (ER) using recombinant ER (RER)

  1993cited by this paper
• Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.

  1990cited by this paper
• Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.

  1989cited by this paper
• Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

  1985cited by this paper

• Evaluation of methods to classify ipsilateral breast tumour recurrences as local recurrence or new primary tumour.

  2026cites this paper
• The Value of Internal Positive Controls and Synthetic Calibrators for Performance Assessment of Breast Carcinoma Estrogen Receptor Immunohistochemistry Assay.

  2026cites this paper
• Reproducibility of Immunohistochemical Testing of Estrogen Receptors, Progesterone Receptors, Human Epidermal Growth Factor Receptor-2 (HER2) and Ki-67 in Vietnam

  2025cites this paper
• Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Expression Rates in Invasive Breast Carcinoma: A Study of 21 Institutions.

  2024cites this paper
• Subtyping of Breast Carcinoma According to ER/PR and HER2/neu Expression: A Cross-Sectional Study from Southern Part of Assam, India

  2024cites this paper
• External Quality Assurance Helps Improve Infrastructure for Testing Breast Biomarkers Across a Lower- and Middle-Income Country: Our Experience With Breast Biomarker Testing in the National Cancer Grid External Quality Assurance System in India.

  2023cites this paper
• Use of Radionuclide-Based Imaging Methods in Breast Cancer.

  2022cites this paper
• Discordance in receptor status between primary and metastatic breast cancer and overall survival: A single-center analysis.

  2022cites this paper
• Commentary on “Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer”

  2022cites this paper
• Receptor conversion impacts outcomes of different molecular subtypes of primary breast cancer

  2021cites this paper
• Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort

  2021cites this paper
• A systematic review of datasets that can help elucidate relationships among gene expression, race, and immunohistochemistry-defined subtypes in breast cancer

  2021cites this paper
• Mobolaji A and Popoola, Abiodun O. Breast cancer receptor status assessment and clinicopathological association in Nigerian women: A retrospective analysis Original Citation Makanjuola,

  2021influential citation
• Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens

  2021cites this paper
• Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma

  2020cites this paper
• SOSYAL HİZMET UYGULAMASINDA MESLEKİ UYGUNLUK ÖLÇEĞİ: GEÇERLİLİK VE GÜVENİRLİK

  2020cites this paper
• Enhanced in vivo targeting of estrogen receptor alpha signaling in murine mammary adenocarcinoma by nilotinib/rosuvastatin novel combination.

  2020cites this paper
• Expression and Clinical Significance of POLR1D in Colorectal Cancer

  2019cites this paper
• Sosyal Hizmet Uzmanlarının Kişisel Ve Mesleki Güç Algıları Ölçeğinin Geçerlilik Ve Güvenirlik Çalışması

  2019cites this paper
• Parallel Reaction Monitoring-Mass Spectrometry (PRM-MS)-Based Targeted Proteomic Surrogates for Intrinsic Subtypes in Breast Cancer: Comparative Analysis with Immunohistochemical Phenotypes.

  2019cites this paper
• Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma.

  2019cites this paper
• The Quantitative ER Immunohistochemical Analysis in Breast Cancer: Detecting the 3 + 0, 4 + 0, and 5 + 0 Allred Score Cases

  2019cites this paper
• Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis

  2018cites this paper
• Expression of Breast Cancer Subtypes Based on the Most Important Biomarkers: Comparison of Clinicopathological Factors and Survival

  2018cites this paper
• Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon

  2018cites this paper
• Fit-for-Purpose Immunohistochemical Biomarkers

  2018cites this paper
• Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Brief fi xation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors , E-cadherin and HER 2 / Neu

  2017cites this paper
• Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

  2017cites this paper
• Assessment of Tumor Stiffness With Shear Wave Elastography in a Human Prostate Cancer Xenograft Implantation Model

  2017cites this paper
• Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu

  2017cites this paper
• Improving accuracy of breast cancer biomarker testing in India

  2017cites this paper
• MAP2 IHC detection: a marker of antigenicity in CNS tissues

  2017cites this paper
• Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors

  2017cites this paper
• An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology

  2017cites this paper
• Breast Cancer Biomarker Changes after Neoadjuvant Chemotherapy: A Single Institution Experience and Literature Review

  2017cites this paper
• Prognostic and predictive value of low estrogen receptor expression in breast cancer.

  2017cites this paper
• Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor

  2016cites this paper
• Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample

  2016influential citation
• An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer

  2016cites this paper
• Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours—a review

  2016cites this paper
• Current Standard Clinical Predictive Markers

  2016cites this paper
• Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

  2016cites this paper
• Prognostic and Predictive Factors of Invasive Breast Cancer

  2016cites this paper
• The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer

  2016cites this paper
• The analytical validation of the Oncotype DX Recurrence Score assay

  2016cites this paper
• Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.

  2016cites this paper
• Bayesian adjustment for the misclassification in both dependent and independent variables with application to a breast cancer study

  2016cites this paper
• Implementation of Immunohistochemistry Assays for Clinical Trial Sample Analyses

  2016cites this paper
• La valeur prédictive et pronostique d'une faible expression des récepteurs d'oestrogènes en cancer du sein

  2015cites this paper
• Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner

  2015cites this paper
• Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country

  2015cites this paper
• Regenerating Gene 1B Silencing Inhibits Colon Cancer Cell HCT116 Proliferation and Invasion

  2015cites this paper
• NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients

  2015cites this paper
• Clinical utility of reverse phase protein array for molecular classification of breast cancer

  2015cites this paper
• Comparison of Clinicopathological Parameters and Molecular Classification of Breast Cancers

  2015cites this paper
• "Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring.

  2015cites this paper
• Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.

  2015cites this paper
• PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis

  2014cites this paper
• Breast cancer molecular subtypes in oman: correlation with age, histology, and stage distribution - analysis of 542 cases.

  2014cites this paper
• Nuclear Notch3 Expression is Associated with Tumor Recurrence in Patients with Stage II and III Colorectal Cancer

  2014cites this paper
• Validation of EP1 Antibody Clone for Estrogen Receptor Immunohistochemistry in Breast Cancer

  2014cites this paper
• Estrogen and progesterone receptors in breast cancer.

  2014cites this paper
• A Quality Initiative of the Program in Evidence-Based Care ( PEBC ) , Cancer Care Ontario ( CCO ) Guideline on Hormone Receptor Testing in Breast Cancer

  2014cites this paper
• NCCN Breast Cancer Version 3 . 2014 Clinical Practice Guidelines in Oncology

  2014cites this paper
• High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.

  2014cites this paper
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

  2014cites this paper
• Genetic aberrations as the targets of oncology research: Involvement of paraffin-embedded tissues.

  2014cites this paper
• Breast cancer version 3.2014.

  2014cites this paper
• Breast cancer receptor status assessment and clinicopathological association in Nigerian women: A retrospective analysis

  2014cites this paper
• Molecular Testing in Breast Cancer

  2014cites this paper
• Study Assessing the Quality of Quantification of Estrogen Receptor Protein Expression by Immunohistochemistry and Gene Expression in Breast Cancer

  2014cites this paper
• Matrilysin-2 expression in colorectal cancer is associated with overall survival of patients

  2014cites this paper
• CD147 Expression in Human Gastric Cancer Is Associated with Tumor Recurrence and Prognosis

  2014cites this paper
• Tropomyosin-related kinase B promotes distant metastasis of colorectal cancer through protein kinase B-mediated anoikis suppression and correlates with poor prognosis

  2014cites this paper
• High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial.

  2014cites this paper
• Histopathological characteristics of breast cancer and evaluation of ER alpha and Her-2neu using immunohistochemical and RT-PCR techniques

  2014cites this paper
• When Tissue Antigens and Antibodies Get Along

  2014cites this paper
• Tissue Microarrays in Studying Gynecological Cancers

  2014cites this paper
• Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions.

  2014cites this paper
• Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification?

  2014cites this paper
• Hormone receptor expression in breast cancer: postanalytical issues

  2013cites this paper
• Correlación entre los cubtipos moleculares intrínsecos en el cáncer de mama por PAM50 y la inmunohistoquímica tumoral

  2013cites this paper
• Matrix Metalloproteinase-14 Is a Negative Prognostic Marker for Patients with Gastric Cancer

  2013cites this paper
• Korelacija između proteinske i genske ekspresije HER-2 i topoizomeraze 2a kod infiltrativnog duktalnog karcinoma dojke

  2013cites this paper
• The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis

  2013cites this paper
• Biology and Treatment of Basal-Like Breast Cancer

  2013cites this paper
• Matrix metalloproteinase‐12 is associated with overall survival in Chinese patients with gastric cancer

  2013cites this paper
• Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer

  2013cites this paper
• HER2 Protein Biomarker Based Sensor Systems for Breast Cancer Diagnosis

  2013cites this paper
• B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells

  2013cites this paper
• Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

  2013cites this paper
• Reliability of receptor assessment on core needle biopsy in breast cancer patients

  2013cites this paper
• Modern Immunohistochemistry in Targeted Therapy

  2013cites this paper
• Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort

  2013cites this paper
• A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.

  2013cites this paper
• In situ Protein Detection for Companion Diagnostics

  2013cites this paper
• Prognostic value of immunohistochemical stratification of invasive duct carcinoma of the breast

  2013cites this paper
• Concordance between Core Needle Biopsy and Surgical Excision Specimens for Tumour Hormone Receptor Profiling According to the 2011 St. Gallen Classification, in Clinical Practice

  2013cites this paper
• Downregulation of BMP6 enhances cell proliferation and chemoresistance via activation of the ERK signaling pathway in breast cancer.

  2013cites this paper